1. Home
  2. WAVE vs TNXP Comparison

WAVE vs TNXP Comparison

Compare WAVE & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

N/A

Current Price

$6.21

Market Cap

43.3M

Sector

Utilities

ML Signal

N/A

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$18.02

Market Cap

231.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAVE
TNXP
Founded
2011
2007
Country
Israel
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
231.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WAVE
TNXP
Price
$6.21
$18.02
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$15.00
$70.00
AVG Volume (30 Days)
12.6K
703.1K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$168,000.00
$10,299,000.00
Revenue This Year
N/A
$14.79
Revenue Next Year
$400.00
$933.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.41
$6.76
52 Week High
$17.38
$130.00

Technical Indicators

Market Signals
Indicator
WAVE
TNXP
Relative Strength Index (RSI) 35.45 48.51
Support Level $6.39 $18.59
Resistance Level $7.00 $19.70
Average True Range (ATR) 0.31 1.26
MACD -0.05 0.25
Stochastic Oscillator 11.54 54.40

Price Performance

Historical Comparison
WAVE
TNXP

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: